These ventures have been with Accelerate Cambridge for over six months and are looking at raising their seed round.
AEMS is developing the next generation AI-driven enterprise software designed for optimising enterprise productivity.
Animal Alternative Technologies
Animal Alternative Technologies is a recently founded biotechnology B2B spin out of the University of Cambridge. We are engineering a scalable, end-to-end ecosystem for Cultured Meat production, including specialist processes, enabling technologies, software, hardware and raw materials to democratize access to sustainable food and tackle some of the world’s biggest sustainability and health challenges.
Antiverse is developing a revolutionary technology to predict antibody drug hits in a single day rather than in months through the traditional methods. A combination of cell-free technology and cutting-edge machine learning is used to develop a proprietary model that recognises and predicts features of antibody-antigen interaction. Ultimately, the customers, who are pharma companies and Contract Research Organisations (CROs), provide us with the sequence of the antigen and Antiverse provides the customers with the sequence of antibodies which bind the antigen with a high affinity. A pharma company and several CROs have already expressed a strong interest in using the service and will also provide support to develop the model as rapidly as possible. Antiverse’s technology will greatly speed up antibody hit discovery and thus enable the development of more, and better, antibody therapeutics against cancer, inflammation and rare diseases.
Anvil is a tool that takes the pain out of software development, without sacrificing power. Companies are best placed to know their own businesses and develop their own business process tools, but developing web applications is hugely slow and complicated. Anvil’s visual designer, simple Python code environment and “batteries-included” philosophy makes business application development faster, easier and more agile.
Biiah (formerly Choral Hub)
Biiah is an app that helps people find the power in their voice. The app and its associated programmes help people build their confidence and better connect with their communities through singing.
Cancer is ranked at the top of global burden of disease, impelling the growth of the global oncology therapeutics market to a size of $250 billion by 2025. Upon pandemic, the liquid biopsy sub-sector has come to the spotlight with a compound annual growth rate of 38.5% for the next four years, paving the way for business development in early cancer diagnosis. While current cancer diagnostics relies on canonical cancer markers that are hardly expressed at early stages, we have leveraged the most advanced technology along with our proprietary pipelines to detect early cancers. Unlike our competitors who selectively capture a subset of cells from peripheral blood, we have developed new testing products to detect and profile all critical cell types in the blood with high sensitivity and specificity. Our products can provide new information on the molecular characteristics of cancer cells and infer tumour locations and metastasis sites. These unique features revolutionise the concept of early cancer diagnosis and are critical for both patients and doctors for personalised medicine. So far, we have a team of six people with diverse backgrounds and expertise and incorporate a new company named BioMavericks.
Cain Medical (formerly HealthBayes)
The recent pandemic has accelerated the Government’s ‘Hospital at Home’ (HAH) initiative which pushes patients out of hospitals into community care to help alleviate the immense pressure placed on hospitals. Consequently, there is an urgent need to provide appropriate access to hospital-level monitoring (ECG, pressures), diagnostics (infectious diseases, cardiology) and interventions using point of care (POC) medical devices placed into communities. Such POC devices are utilised in post-hospital but also pre-hospital care, preventing some patients from going into hospital in the first place.
Cain Medical has developed a hardware and software solution to enable secure, real-time data links into hospital networks. Our product enables paramedics, GPs, nursing homes and other satellite sites to be supported by experts in secondary care such as pathology labs and cardiologists. We facilitate time-critical interventions and data-based clinical decision making in line with HAH’s strategic vision to improve patient care and clinical outcomes with more efficient use of resources.
We specialise in medical device integration for hospital Intensive Care Unit (ICU) and pathology. Our solution facilitates the automatic recording of patient data from medical equipment to cut out inefficient manual transcription of data by medical staff, which is labour intensive and prone to errors. This puts us in the strong position to utilize our expertise and extend data transmission beyond the boundaries of hospitals into the community.
More importantly, our product decodes medical information in a standardised format which allows data from different medical devices to be integrated with each other which opens the door for more sophisticated machine learning and AI algorithms to explore diagnostic predictors. Another key feature is our high standard of security. We do not store any clinical data but pass them with two-key, end to end encryption. Information flow is further secured with a bespoke monitoring system that only allows data to pass that match pre-specified features (eg size and volume) defined by the POC device.
The long-term vision of Cain Medical is to provide an infrastructure that facilitates community-based contextualise healthcare by combining multimodal medical data with other social and behavioural determinants which will improve patient care and clinical outcomes.
Cambridge Creative Education Centre
Cambridge Creative Education Centre is aimed for providing diverse creative education courses for different countries. Creative Education is to use creative pedagogies and educational theories to support education in different ways. The company has a strong research team with senior researchers and lecturers from the Faculty of Education, University of Cambridge. The first course is “Learning English through Drama for Years 3-12” based on the drama pedagogy research. The course includes a full package of curriculum, teacher training, textbooks and teaching tools. The teacher training system is also developed for all English teachers around the world. The company also organises study tours for teachers and students to experience creative education in Cambridge.
CodiKoat has developed the world’s first anti-viral surface coating that blends electricity and chemistry to provide simple, immediate and long-lasting protection against microbes and viruses, including COVID-19.
deepMirror accelerates biomedical research with powerful and easy to use AI software tools. Our cloud-based web applications simplify complex data analysis workflows to save researchers hours of their time. Our clients can gain access to our growing portfolio of existing software tools, or partner with us to create new software solutions to tackle their biomedical data analysis.
One in 10 children suffers from migraines. Migraines are severely impacting the development of the young patients physically, emotionally and socially. Cognitive behavioural therapy (CBT) has proven to work effectively for children with migraines. However, as there are not enough psychotherapists who are specialised in CBT for paediatric migraine patients the psychological treatment is neglected. Happyr Health makes CBT access possible for young migraine sufferers. Personalised and on a population scale. By combining scientific evidence with the latest applied gaming technology, Happyr Health creates an experience for suffering children that is not only helpful but also playful.
In2Med aims to be a learning resource where you can learn medicine from the basics. Created by medical students, this venture is the first of its kind platform helping students right from the beginning of their medical careers in sixth form, through medical school and beyond.
iWarranty is developing a cloud-based solution to eliminate the existing paper-based warranties and manual claim processes. The focus innovation will be in the application of existing and expanding technological development in artificial intelligence (AI) and machine learning (ML) to create process efficiencies for manufacturers.
iWarranty’s warranty intelligence platform facilitates significant cost reduction and efficiency in terms of warranty management, thereby driving better long-term margin. At the same time, it helps to build brand loyalty and repeat purchases and manage one-to-one customer experience by creating a personalised post-sale customer journey that delivers exceptional brand experience throughout the entire product lifecycle. iWarranty offers consumers convenience and peace of mind when it counts the most! iWarranty’s free mobile apps capture receipts, register products, summarises key warranty terms and allows consumers to make and manage a claim from anywhere anytime.
Kestrl aims to be the world’s first 100% ethical banking and wealth management platform. Kestrl is for people who want to combine their financial needs with their personal values in order to truly change the world for the better.
Kitchens Confidential combines turnkey cloud kitchen space with technology-enabled back-office support. The space is fully built-out with dedicated separate kitchens for each restaurant, and industry-standard equipment. The technology stack includes features such as predictive ordering, menu optimisation, delivery management, digital marketing, and payment API integration. By combining the physical and digital, we provide a platform for restaurants to survive and thrive in a take-away driven market.
Lionheart Lifting is bringing a new brand of fitness equipment to the market designed around the needs of military members and those who work or live in uniquely challenging conditions. With U.S. military experience on the founding team, we are developing a value proposition that addresses space requirements, anti-microbial needs, durability, and many other features that fall short in serving this demanding space. Utilising military agencies as a beachhead for market penetration, Lionheart will also serve the private sector as the go-to brand for military level fitness and physical discipline.
Lumino is on a mission to bring better mental health to everyone. Right now, one in five people are experiencing a mental health problem. However, most will have not have access to effective treatment. Our goal is to reinvent how mental health treatment is delivered, through developing truly scalable, world-leading digital therapeutic programmes. We combine a strong focus on clinical outcomes with great design. Lumino is supported by Innovate UK and the Eastern Academic Health Science Network.
Medwise.ai is the Google for doctors, saving doctors two minutes per query in 10 minutes GP consultation. We use artificial intelligence to provide instant clinical answers to doctors at the point of care. Our mission is to empower healthcare professionals so every patient receives the best care possible. We are founded by a team of doctors, AI scientists and software engineers.
mySymptoms (formerly SkyGazer Labs)
mySymptoms mission is to improve the health of sufferers of chronic gut conditions by nutrition, lifestyle, and outcome analysis. mySymptoms was one of the first digital health companies to launch a smartphone app – ‘mySymptoms’ – in the Apple App Store, followed later by an Android version.
After identifying an emerging market for digital health products, mySymptoms then began development of a data platform to facilitate clinical services, academic and medical research, along with more advanced analytics using machine learning. The company is shortly due to launch a pilot of its new clinical app, moving the company firmly into the clinical marketplace. mySymptoms is currently funded by revenues from its smartphone app, mySymptoms, and is privately held by its two founders, Darren Launders and Damian Helme.
As chemotherapy suppresses the immune system, even a mild illness can be fatal for chemotherapy patients. The suppression of a white blood cell known as the neutrophil, can lead to neutropenic sepsis, a life-threatening medical emergency. Therefore, chemotherapy patients with even mild signs of infection at home are brought into hospital for blood tests to check their neutrophil levels and, while awaiting results, given intravenous antibiotics as a precaution. Six in 10 patients turn out to have normal neutrophil counts, and therefore did not necessarily need to attend hospital, costing the NHS approximately £40 million each year.
NeutroCheck was launched to develop a transformative new medical device, NeutroCheck, presenting tangible efficiencies in patient care and healthcare resource, both financial and human. The device will be used in the patient’s home to give a near-instant measure of the patient’s neutrophil levels using blood from a small pin-prick. The NeutroCheck device is designed to be portable and easy-to-use in a home environment.
Our focus is to produce a fast, reliable and low-cost device which would improve safety and quality of life for cancer patients worldwide, whilst saving healthcare institutions such as the NHS millions of pounds each year from substantially reducing hospital visits.
Ever gone to streaming sites like Netflix and you just couldn’t decide what to watch? And every day new streaming sites are coming up. There is a lot of content, and the user spends more time searching than watching. QuirkyByte+ is an app which aims to solve this problem, by recommending content, using a proprietary algorithm. It collects data from all streaming sites, and then recommends content to the user using our own machine learning model. It is loaded with features, which any user will require for entertainment discovery purpose. While most apps, are trying to increase usage time on their apps, we are trying to reduce it, and that is our business model. Just Netflix spends hundreds of millions of dollars for their recommendation algorithm, and yet users are still not finding content easily. With the libraries expanding daily, it is time content discovery becomes easier, and that too for a fraction of the cost for the user with multitude of benefits. All this while saving the most important resource any human has – time.
S4 is an Earth imaging company developing self-aligning unfolding space telescopes. The use of Earth imagery in everyday life is rapidly growing such as for navigation. Other important examples include monitoring the environment, gaining insights for making investment decisions, as well as maintaining global security. These applications require an Earth imaging platform that captures images with greater detail and that captures imagery of the same location more often.
Capturing greater detail (or ‘resolution’) requires a bigger telescope. Capturing imagery (or ‘revisiting’) of the same location more often requires many of these telescopes. Satellite cost increases greatly with satellite size, so such a constellation of satellites simply isn’t affordable.
At S4 we’re developing the ultimate solution for this problem. Telescopes typically don’t unfold because their optics must be very accurately positioned – to better than one hundredth of the width of a human hair. Our fundamental innovation is our patent pending self-alignment technology which positions our optics with this extreme accuracy. At S4 we can fit a large telescope in a small box (or nanosatellite), making low cost, high resolution, high revisit Earth imaging possible.
Skinlync is a digital health platform that allows users with a skin condition to instantly connect with other users who have a similar condition and profile, enabling the exchange of valuable insights and emotional support. Users also have the option to learn medically approved ways to manage their condition and log their self-management activities, all on one platform. Ultimately, Skinlync aims to become the go-to self-management tool in dermatology. Skinlync will be officially launched in July 2020.
Sotera Heritage (formerly AAI)
Sotera Heritage is using AI to combat the global trade in stolen and looted antiquities. The illegal trade damages world heritage, funds terrorism and fuels the black market. Our goal is to make it easier for border guards, law enforcement, legitimate dealers, insurance companies and collectors to spot stolen or looted objects as they move around the world. The product will incorporate live datasets, such as databases of known stolen objects, and specific object types prone to being traded illegally.
Sotera Heritage was founded through the University of Cambridge Accelerate Program at Judge Business School. The team has extensive backgrounds and networks in archaeology and heritage, security and law enforcement, technology and AI.
Spliceor, a Cambridge University spin-out, has developed a novel, patented cancer gene therapy platform to progress curative treatments for the most aggressive cancers that respond poorly to alternative treatments. We have identified a highly accessible and widely expressed cancer cell target for our disruptive cancer-selective therapies. Liver and pancreatic cancers are the initial indications, but the approach is applicable to many other malignancies. Our mission is to provide curative and easily tolerated gene therapies to cancer patients.
Technology has the potential to expand the accessibility of complex subjects and to reduce widening learning gaps that are hindering our society. Developed by a team of Cambridge academics, Summatic is an intelligent platform for learning, teaching, and assessing maths-based subjects, using automated questioning and interactive graphs. We are delivering comprehensive learning resources to thousands of students in UK schools and universities, with the aim of also being a leading international provider of advanced maths education, as well as a platform for publishers to deploy online content.
Swift Molecular Diagnostics
Swift Molecular Diagnostics have created a novel technology that allows the development of self-contained diagnostic devices for the fast, accurate and low-cost genetic detection that do not require laboratory facilities or trained personnel.
We have filed the patent application of our technology and we aim in the first instance to implement our technology to detect antibiotic resistance from patients, allowing the effective treatment of bacterial infections and fast response in acute cases such as bacteraemia and septicaemia.
Swing is a fittech start-up that provides pay-as-you-go free-weights and online classes in green spaces. Our goal is to provide easy and affordable access to outdoor fitness equipment across the UK; thereby reducing health inequality and promoting green space exercise. Each micro-gym will have an adjustable back-rest (and lid) that can be used as a bench or step. Within the micro-gym there will be a set of adjustable kettlebells, dumbbells, and one or two other pieces of fitness equipment. Users can access the contents by scanning a QR code with their smartphone. Lime scooters meets Peloton!
Vector Bioscience Cambridge works with enhanced and targeted treatments for cancer. Our tailored platform technology based on specific porous materials called metal-organic frameworks improve drugs’ efficacy and safety. Vector is a spinout from UCAM.
Get in touch to find out more!
ZORB provides cyber protection for employees who need to access confidential data from outside of the corporate office.
The trend towards hybrid working can introduce some big challenges to meeting data compliance. Anti-virus and VPN can only go so far in protecting your remote workers against data loss, malware, ransomware and cyberattacks.
Step up to the next level of digital protection – protect your data, your staff and your business for less than £1 per homeworker per day.